Varaico: Literature-Extracted Genetic Variants

Gene:CASQ2
Variant:p.Y55C
Back to variants list

CASQ2

NM_001232.4:p.Y55C

Associated Papers

The emerging role of calsequestrin 2: from calcium sensor and modulator to arrhythmia driver.

Rajha HE et al.

Journal of Physiology and Biochemistry, 2026

[Catecholaminergic Polymorphic Ventricular Tachycardia Caused by a Homozygous Pathogenic Variant in Calsequestrin 2 Gene].

Komissarova SM et al.

Kardiologiia, 2025

A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome.

Ni M et al.

Jama, 2024

Catecholaminergic polymorphic ventricular tachycardia (and seizure) caused by a novel homozygous likely pathogenic variant in CASQ2 gene.

Askarinejad A et al.

Gene, 2024

Importance of exercise stress testing in evaluation of unexplained cardiac arrest survivor.

Bergeman AT et al.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2023

The function and regulation of calsequestrin-2: implications in calcium-mediated arrhythmias.

Sibbles ET et al.

Biophysical Reviews, 2022

An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia.

Ng K et al.

Circulation, 2020

Calsequestrin. Structure, function, and evolution.

Wang Q et al.

Cell Calcium, 2020

CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia.

Li Q et al.

Molecular Genetics & Genomic Medicine, 2019

Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance.

van Lint FHM et al.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2019

30847666 (PubMed )
Supplement: 12471_2019_1250_MOESM2_ESM.xlsx › Blad1

New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia.

Jabbari J et al.

Circulation. Cardiovascular Genetics, 2013

24025405 (PubMed )
Supplement: 000118_supplemental_material.pdf

Catecholaminergic polymorphic ventricular tachycardia.

Leenhardt A et al.

Circulation. Arrhythmia and Electrophysiology, 2012

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.

Faggioni M et al.

Pediatric Cardiology, 2012

Calsequestrin 2 and arrhythmias.

Faggioni M et al.

American Journal of Physiology. Heart and Circulatory Physiology, 2012

Functional analysis reveals splicing mutations of the CASQ2 gene in patients with CPVT: implication for genetic counselling and clinical management.

Roux-Buisson N et al.

Human Mutation, 2011

Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis.

Priori SG et al.

Circulation Research, 2011

A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations.

de la Fuente S et al.

Pacing and Clinical Electrophysiology : Pace, 2008

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."